Efficacy and Safety of IBI110 in Combination with Sintilimab and Lenvatinib in First-Line of Advanced Hepatocellular Carcinoma: Preliminary Results from a Phase Ib Study
JOURNAL OF CLINICAL ONCOLOGY(2023)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要